Eyenovia Inc Total Liabilities
Eyenovia Inc total liabilities. Based on the latest financial reports, Eyenovia Inc (EYEN) has total liabilities worth $15.70 Million USD as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Eyenovia Inc (EYEN) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Eyenovia Inc (2015–2024)
Total liabilities of Eyenovia Inc from 2015 to 2024. This chart illustrates how Eyenovia Inc's total liabilities have evolved over time, based on quarterly financial data.
Eyenovia Inc Competitors by Total Liabilities
The table below lists competitors of Eyenovia Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hanjin Heavy Ind & Const Holdings Co Ltd
KO:003480
|
Korea | ₩1.21 Trillion |
|
Huikwang
TWO:6508
|
Taiwan | NT$412.10 Million |
|
Can One Bhd
KLSE:5105
|
Malaysia | RM2.67 Billion |
|
Igis Residence Reit Co Ltd
KO:350520
|
Korea | ₩102.05 Billion |
|
OFX Group Ltd
AU:OFX
|
Australia | AU$514.38 Million |
|
Prospector Metals Corp
V:PPP
|
Canada | CA$439.50K |
|
Seronics Co. Ltd
KQ:042600
|
Korea | ₩118.34 Billion |
|
C-Media Electronics
TWO:6237
|
Taiwan | NT$190.06 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Eyenovia Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see EYEN asset base.
Liquidity & Leverage Metrics
Eyenovia Inc Total Liabilities Ratios Explained
Eyenovia Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.62 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.62 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Eyenovia Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Eyenovia Inc (2015–2024)
The table below shows the annual total liabilities of Eyenovia Inc from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $16.76 Million | -15.25% |
| 2023-12-31 | $19.78 Million | +43.32% |
| 2022-12-31 | $13.80 Million | +23.31% |
| 2021-12-31 | $11.19 Million | -39.83% |
| 2020-12-31 | $18.60 Million | +529.11% |
| 2019-12-31 | $2.96 Million | -5.84% |
| 2018-12-31 | $3.14 Million | +468.25% |
| 2017-12-31 | $552.65K | +30.42% |
| 2016-12-31 | $423.73K | +0.93% |
| 2015-12-31 | $419.82K | -- |
About Eyenovia Inc
Eyenovia, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vi… Read more